Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

82 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Molecular requirements for epithelial-mesenchymal transition during tumor progression.
Huber MA, Kraut N, Beug H. Huber MA, et al. Curr Opin Cell Biol. 2005 Oct;17(5):548-58. doi: 10.1016/ Curr Opin Cell Biol. 2005. PMID: 16098727 Review.
NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells.
Maier HJ, Schmidt-Strassburger U, Huber MA, Wiedemann EM, Beug H, Wirth T. Maier HJ, et al. Among authors: huber ma. Cancer Lett. 2010 Sep 28;295(2):214-28. doi: 10.1016/j.canlet.2010.03.003. Epub 2010 Mar 29. Cancer Lett. 2010. PMID: 20350779
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
Huber MA, Azoitei N, Baumann B, Grünert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T. Huber MA, et al. J Clin Invest. 2004 Aug;114(4):569-81. doi: 10.1172/JCI21358. J Clin Invest. 2004. PMID: 15314694 Free PMC article.
BI 5700, a Selective Chemical Inhibitor of IκB Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression.
Huber MA, Maier HJ, Alacakaptan M, Wiedemann E, Braunger J, Boehmelt G, Madwed JB, Young ER, Marshall DR, Pehamberger H, Wirth T, Kraut N, Beug H. Huber MA, et al. Genes Cancer. 2010 Feb;1(2):101-14. doi: 10.1177/1947601910361749. Genes Cancer. 2010. PMID: 21779445 Free PMC article.
Epithelial-mesenchymal transition: NF-kappaB takes center stage.
Huber MA, Beug H, Wirth T. Huber MA, et al. Cell Cycle. 2004 Dec;3(12):1477-80. doi: 10.4161/cc.3.12.1280. Epub 2004 Dec 4. Cell Cycle. 2004. PMID: 15539952
Expression of stromal cell markers in distinct compartments of human skin cancers.
Huber MA, Kraut N, Schweifer N, Dolznig H, Peter RU, Schubert RD, Scharffetter-Kochanek K, Pehamberger H, Garin-Chesa P. Huber MA, et al. J Cutan Pathol. 2006 Feb;33(2):145-55. doi: 10.1111/j.0303-6987.2006.00446.x. J Cutan Pathol. 2006. PMID: 16420310
The IKK-2/Ikappa Balpha /NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha -deficient mice.
Huber MA, Denk A, Peter RU, Weber L, Kraut N, Wirth T. Huber MA, et al. J Biol Chem. 2002 Jan 11;277(2):1268-75. doi: 10.1074/jbc.M109358200. Epub 2001 Nov 2. J Biol Chem. 2002. PMID: 11694538
Key drivers of biomedical innovation in cancer drug discovery.
Huber MA, Kraut N. Huber MA, et al. EMBO Mol Med. 2015 Jan;7(1):12-6. doi: 10.15252/emmm.201404596. EMBO Mol Med. 2015. PMID: 25422355 Free PMC article.
Oral Potentially Malignant Disorders and Oral Cavity Cancer.
Ojeda D, Huber MA, Kerr AR. Ojeda D, et al. Among authors: huber ma. Dermatol Clin. 2020 Oct;38(4):507-521. doi: 10.1016/j.det.2020.05.011. Epub 2020 Aug 11. Dermatol Clin. 2020. PMID: 32892859 Review.
Self-managed programmes in homeless care as (reinvented) institutions.
Huber MA, Metze RN, Stam M, Regenmortel TV, Abma TA. Huber MA, et al. Int J Qual Stud Health Well-being. 2020 Dec;15(1):e1719002. doi: 10.1080/17482631.2020.1719002. Int J Qual Stud Health Well-being. 2020. PMID: 31973667 Free PMC article.
82 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page